Wladimir Hogenhuis
CIK 1755074 · View on SEC EDGAR ↗
First SEC filing: Dec. 17, 2025 · Latest: Dec. 17, 2025
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | RZLT | P | 5,650 | $1.69 | $9,548 | 119,675 Direct | +4.96% | Acquired | 190.2% (price as of 2026-08-21) |
| March 31, 2025 | RZLT | P | 6,758 | $2.92 | $19,733 | 84,025 Direct | +8.75% | Acquired | 68.0% (price as of 2026-08-21) |
| Feb. 18, 2025 | RZLT | P | 10,000 | $4.70 | $47,000 | 77,267 Direct | +14.87% | Acquired | 4.4% (price as of 2026-08-21) |
| Sept. 24, 2024 | RZLT | P | 4,259 | $4.70 | $20,017 | 41,767 Direct | +11.35% | Acquired | 4.4% (price as of 2026-08-21) |
| June 25, 2024 | RZLT | P | 4,815 | $4.15 | $19,982 | 37,508 Direct | +14.73% | Acquired | 18.2% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 19, 2025 | RZLT | Director Stock Option (Right to Buy) | Common Shares (12,000) | $10.16 | Nov. 19, 2035 | 12,000 | Acquired |
| June 10, 2025 | RZLT | Director Stock Option (Right to Buy) | Common Shares (5,000) | $4.39 | June 10, 2035 | 5,000 | Acquired |
| Feb. 16, 2025 | RZLT | Director Stock Option (Right to Buy) | Common Shares (15,000) | $4.61 | Feb. 16, 2035 | 15,000 | Acquired |
| Jan. 23, 2024 | RZLT | Director Stock Option (Right to Buy) | Common Shares (30,000) | $1.02 | Jan. 23, 2034 | 30,000 | Acquired |
| March 1, 2019 | RARE | Stock Option (Right to Buy) | Common Stock (11,000) | $67.55 | March 1, 2029 | 11,000 | Acquired |
| Oct. 4, 2018 | RARE | Stock Option (Right to Buy) | Common Stock (75,000) | $77.30 | Oct. 4, 2028 | 75,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $110,923 | $200,000 | — | — | $67,021 | — | $215,827 | $5,257,804 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.